| CENTER ID: | MyleA.00730.a |
| ORGANISM: | Mycobacterium leprae Br4923 |
| ASSOCIATED DISEASE: | Hansen's disease, leprosy |
| CURRENT STATUS: | in PDB |
| COMMUNITY REQUEST: | True |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
IIIC |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| MyleA.00730.a.A1.GE34158 | full length | 1 | 160 |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| MyleA.00730.a.A1.PS01466 | full length | 1 | 160 |
| Biomedical Applications of Lumazine Synthase | |
| Y Wei, P Kumar, N Wahome, NJ Mantis- Journal of, 2018 - Elsevier | |
| cited by: | 20 others |
| PDB: 4J07 | |
| Strategies to improve the immunogenicity of subunit vaccine candidates | |
| Y Wei - 2018 - kuscholarworks.ku.edu | |
| cited by: | 1 other |
| PDB: 4J07 | |
| Crosslinked helix dimers as versatile scaffolds for mimicking topologically complex epitopes | |
| MG Wuo - 2018 - search.proquest.com | |
| PDB: 4J07 |
| The eradication of leprosy: molecular modeling techniques for novel drug discovery | |
| S Anusuya, J Natarajan - Expert opinion on drug discovery, 2013 - informahealthcare.com | |
| PDB: 4J07 |
| RESOURCE | REFERENCE ID |
|---|---|
| BV-BRC: | fig|561304.4.peg.968 |
| RefSeq: | YP_002503105.1 |
| UniProt: | B8ZUN3 |
| HARVESTED ON: | 12/6/2011 |
| SEQUENCED ON: | 12/8/2011 |
| EXPECTED MW: | 18kDa |
| OBSERVED MW: | 18kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Many (50-100) |
| TOTAL EXPRESSION LEVEL: | Low Expression |
| SOLUBLE EXPRESSION LEVEL | Low Expression |
| EXPRESSION HOST: | data unavailable |
| SEQUENCING RESULT: | pass with incomplete coverage |
| PERCENT IDENTITY: | 100 |
| PERCENT COVERAGE: | 100 |
| PURIFICATION DATe: | 4/18/2012 |
| CONCENTRATION: | 46.06mg/ml |
| OBSERVED MW: | 17kDa |
| EXPRESSION LEVEL: | Low Expression |
| PROTEIN PURIFICATION BUFFER: | 20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP |
| EXPRESSION HOST: | data unavailable |
| VIAL COUNT (approx.): | 1 |
| VIAL VOLUME: | 110µl |
| PERCENT IDENTITY: | 100 |
| PERCENT COVERAGE: | 100 |